Arab Drug Dividends and Buybacks
Dividend criteria checks 5/6
Arab Drug is a dividend paying company with a current yield of 8.09% that is well covered by earnings.
Key information
8.1%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 8.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ج.م8.350 |
| Payout ratio | 57% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ADCI's dividends per share have been stable in the past 10 years.
Growing Dividend: ADCI's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Arab Drug Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ADCI) | 8.1% |
| Market Bottom 25% (EG) | 2.0% |
| Market Top 25% (EG) | 7.4% |
| Industry Average (Pharmaceuticals) | 3.1% |
| Analyst forecast (ADCI) (up to 3 years) | n/a |
Notable Dividend: ADCI's dividend (8.09%) is higher than the bottom 25% of dividend payers in the EG market (1.99%).
High Dividend: ADCI's dividend (8.09%) is in the top 25% of dividend payers in the EG market (7.3%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (56.7%), ADCI's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: ADCI is paying a dividend but the company has no free cash flows.